Bionano Genomics Inc (NAS:BNGO)
$ 0.904 -0.026 (-2.8%) Market Cap: 62.47 Mil Enterprise Value: 49.37 Mil PE Ratio: 0 PB Ratio: 0.63 GF Score: 44/100

Bionano Genomics Inc Annual Shareholders Meeting Transcript

Jun 10, 2021 / 05:00PM GMT
Release Date Price: $76.4 (-1.67%)
Robert Erik Holmlin
Bionano Genomics, Inc. - President, CEO, Secretary & Director

Good morning. I am Erik Holmlin, Chief Executive Officer, Secretary and a Director of Bionano Genomics. I'm very happy to welcome you to the Bionano 2021 Annual Meeting of Stockholders.

Before I call the meeting to order, I would like to introduce you to the members of our Board and our business team who are with us here today. Since the meeting is being held virtually via live webcast, we have stockholders attending via web portal. In attendance today are Bionano's Chief Operating Officer, Mark Oldakowski; Chris Stewart, our Chief Financial Officer; Alka Chaubey, our Chief Medical Officer; Jason Prior, our Chief Commercial Officer; and Al Luderer from our Board of Directors. I would also like to introduce Bo Monaco of BDO USA LLP, Bionano's auditors; and Brandon Marsh of Cooley LLP, Bionano outside counsel, who are available to respond to appropriate questions.

The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in the notice of annual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot